0 Items
Select Page

Mumps Virus

Mumps is a highly contagious disease caused by the mumps virus (MuV). The virus primarily affects children causing a self-limiting febrile illness with inflammation of the salivary glands. Infection in adults can lead to clinical complications including orchitis in men. Since the 1960’s, the introduction of an effective vaccine and a widespread vaccination program has significantly reduced cases of mumps. However, recent outbreaks of mumps in vaccinated individuals have been reported causing concern in the global health community.

Mumps Virus Background

Mumps virus (MuV) is a single stranded negative-sense RNA virus, which belongs to the Rubulavirus genus of the family Paramyxoviridae. The viral genome is contained within a nucleocapsid enclosed by a lipid envelope that consists of three layers. The outer layer contains glycoproteins which have neuraminidase, hemagglutinin and cell-fusion (F-protein) activities. One serotype and 13 genotypes of MuV have been identified to date.

Mumps, also known as infectious parotitis, is a highly contagious disease caused by the mumps virus.  MuV is globally widespread and predominantly affects children but can also cause disease in adults. Humans are the only known host of mumps virus and infection is spread from person-to-person via respiratory aerosol droplets, saliva and direct contact with infected individuals (WHO).

Mumps infection is typically a mild self-limiting disease, which resolves within 2-3 weeks of symptom onset. The disease is asymptomatic in a third of cases, but individuals can still be contagious. When symptoms of MuV infection occur they include headache, fever and general malaise followed by inflammation and swelling of the parotid glands. The MuV can also cause inflammation in other organs including the testes causing orchitis, which may lead to testicular atrophy in males post puberty. The virus is also highly neutrophic and may cause complications in some cases of MuV infection, such as aseptic meningitis, viral encephalitis and transient deafness (Rubin, S).

Since the introduction of an effective vaccine in the 1960’s, global cases of Mumps have been in decline. However, outbreaks of MuV in vaccinated individuals and complications associated with some vaccine strains have been reported in recent years. These cases have been a cause for concern and have renewed interest in the mumps virus.

References

Mumps Virus Antigens

We are pleased to offer a recombinant Mumps virus lysate for research use. This lysate can be used as an antigen, for the purification of viral proteins, or in assays for the detection of viral antibodies.

Mumps Virus Antibodies

We are pleased to offer a selection of Mumps virus antibodies, suitable for the development of ELISA and other immunoassays.

Mumps Virus Immunoassays

We are pleased to offer Mumps virus ELISA assays in both IgG and IgM format. These assay kits have high sensitivity and specificity and are suitable for research use and disease surveillance. 

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Novel Coronavirus Antigens Now Available

The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for the 2019 Novel Coronavirus (SARS-CoV-2, Covid-19) in response to urgent demand. These reagents are suitable for use in basic research and the development of diagnostics and...

The Why and How of Protein Conjugation

In this blog, Lead Assay Development Scientist, Toni Ertl discusses the basics of protein conjugation and introduces our new range of conjugation kits for the labelling of antigens and antibodies.Detecting Proteins If you’re trying to detect or measure the presence...

Going Viral: Why We Need New Diagnostics For a Safe and Effective Dengue Vaccine

This article is taken from European Biopharmaceutical Review January 2020, pages 44-46. © Samedan Ltd.The Dengue VirusDengue is the world’s most prevalent and consequential arboviral disease. Current estimates indicate that as many as 390 million dengue infections...

Why We Need New Diagnostics for the Zika Virus

This article has been published in Volume 2, Issue 3 of the IBI journal.While Zika is no longer in the public eye, it hasn’t vanished. Recent outbreaks across Asia and Africa are reminders that Zika is alive and well, and with no effective countermeasures...

Clostridium difficile Toxins: The Nuts and Bolts

In this blog, we describe the mechanisms of action of the Clostridium difficile A and B toxins, and discuss their use in research and medicine. The Native Antigen Company provides biologically active C. diff toxins, as well as inactivated toxoids for a range of...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

7 + 6 =

Live Customer Feedback

Join our mailing list

* indicates required